[Anticoagulation in patients with chronic kidney disease : Recommendations from the working group "Heart-Kidney" of the German Cardiac Society and the German Society of Nephrology]
- PMID: 28396914
- DOI: 10.1007/s00108-017-0220-5
[Anticoagulation in patients with chronic kidney disease : Recommendations from the working group "Heart-Kidney" of the German Cardiac Society and the German Society of Nephrology]
Abstract
Indications for anticoagulation are thromboembolic events, prosthetic heart valves, and atrial fibrillation with a corresponding risk score. Clinical trials have excluded patients with advanced chronic kidney disease and these data cannot be always generalized to patients with chronic kidney disease. Non-vitamin K antagonist oral anticoagulants (NOACs) are mostly not recommended or are contraindicated in advanced stages of chronic kidney disease. Observational studies have shown that dialysis patients with atrial fibrillation do not profit from coumarin anticoagulants; prospective studies are lacking.
Keywords: Anticoagulants; Atrial fibrillation; Phenprocoumon; Renal disease; Warfarin.
Similar articles
-
Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.Thromb Res. 2017 Jul;155:38-47. doi: 10.1016/j.thromres.2017.04.027. Epub 2017 May 4. Thromb Res. 2017. PMID: 28482261 Review.
-
[Non vitamin-K dependent oral anticoagulants (NOACs) in chronic kidney disease patients with non-valvular atrial fibrillation].G Ital Nefrol. 2017 Apr;34(2):58-73. G Ital Nefrol. 2017. PMID: 28682563 Review. Italian.
-
[NOACs and Chronic kidney disease].G Ital Nefrol. 2017 Mar;34(Suppl 69):188-204. G Ital Nefrol. 2017. PMID: 28682039 Review. Italian.
-
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.Europace. 2015 Oct;17(10):1467-507. doi: 10.1093/europace/euv309. Epub 2015 Aug 31. Europace. 2015. PMID: 26324838
-
Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs.Lancet. 2015 Jul 18;386(9990):303-10. doi: 10.1016/S0140-6736(15)60245-8. Epub 2015 Mar 14. Lancet. 2015. PMID: 25777666 Review.
Cited by
-
[Cardiovascular diagnostic testing in advanced chronic kidney disease: which tests are useful?].Internist (Berl). 2020 Apr;61(4):349-356. doi: 10.1007/s00108-019-00737-4. Internist (Berl). 2020. PMID: 31938817 Review. German.
-
Oral Anticoagulation in Chronic Kidney Disease and Atrial Fibrillation.Dtsch Arztebl Int. 2018 Apr 27;115(17):287-294. doi: 10.3238/arztebl.2018.0287. Dtsch Arztebl Int. 2018. PMID: 29789105 Free PMC article. Review.
-
Treatment standards for direct oral anticoagulants in patients with acute ischemic stroke and non-valvular atrial fibrillation: A survey among German stroke units.PLoS One. 2022 Feb 17;17(2):e0264122. doi: 10.1371/journal.pone.0264122. eCollection 2022. PLoS One. 2022. PMID: 35176109 Free PMC article.
-
Biased Results Owing to Competing Interests?Dtsch Arztebl Int. 2018 Sep 14;155(37):606. doi: 10.3238/arztebl.2018.0606a. Dtsch Arztebl Int. 2018. PMID: 30282574 Free PMC article. No abstract available.
-
Percutaneous left atrial appendage closure for stroke prevention in patients with chronic renal disease.Arch Med Sci. 2020 Feb 25;19(2):331-336. doi: 10.5114/aoms.2020.92987. eCollection 2023. Arch Med Sci. 2020. PMID: 37034526 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical